Modified bleomycin disaccharides exhibiting improved tumor cell targeting

Biochemistry

Volumn 53, Issue 43, 2014, Pages 6800-6810

  Madathil, Manikandadas M ^a   Bhattacharya, Chandrabali ^a   Yu, Zhiqiang ^a   Paul, Rakesh ^a   Rishel, Michael J ^b   Hecht, Sidney M ^a  

^a ARIZONA STATE UNIVERSITY   (United States)

^b GE GLOBAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTICS; BIOCATALYSTS; CELL CULTURE; CHEMOTHERAPY; TUMORS;

ANTI-CANCER CHEMOTHERAPY; ANTI-TUMOR AGENTS; ANTI-TUMORS; ANTITUMOR ANTIBIOTICS; CANCER CELL LINES; CARBAMOYL GROUPS; CYANINE DYES; STRUCTURAL ANALOGUE;

CELLS;

BLEOMYCIN; DISACCHARIDE; DYE; ANTINEOPLASTIC ANTIBIOTIC; CARBOCYANINE; CYANINE DYE 5;

ARTICLE; CANCER CELL LINE; CARBOHYDRATE ANALYSIS; CONTROLLED STUDY; DRUG BINDING; DRUG CONJUGATION; DRUG SYNTHESIS; DRUG TARGETING; DRUG UPTAKE; HUMAN; HUMAN CELL; TUMOR CELL; CHEMISTRY; DRUG DELIVERY SYSTEM; NEOPLASMS; TUMOR CELL LINE;

ANTIBIOTICS, ANTINEOPLASTIC; BLEOMYCIN; CARBOCYANINES; CELL LINE, TUMOR; DISACCHARIDES; DRUG DELIVERY SYSTEMS; HUMANS; NEOPLASMS;

EID: 84908569682     PISSN: 00062960     EISSN: 15204995     Source Type: Journal    
DOI: 10.1021/bi501102z     Document Type: Article

References (33)

1. Umezawa, H., Suhara, Y., Takita, T., and Maeda, K. (1966) Purification of bleomycins J. Antibiot. 19, 210-215
2. Levi, J. A., Raghavan, D., Harvey, V., Thompson, D., Sandeman, T., Gill, G., Stuart-Harris, R., Snyder, R., Byrne, M., and Kerestes, Z. (1993) The importance of bleomycin in combination chemotherapy for good-prognosis germ cell carcinoma. Australasian germ cell trial group J. Clin. Oncol. 11, 1300-1305
3. Hecht, S. M. (1999) Bleomycin: new perspectives on the mechanism of action J. Nat. Prod. 63, 158-168
4. Hecht, S. M. (2012) Bleomycin group antitumor agents, in Anticancer Agents from Natural Products (Cragg, G. M., Kingston, D. G. I., and Newman, D. J., Eds.) 2 nd ed., pp 451-478, CRC Press, Boca Raton, FL.
5. Povirk, L. F., Han, Y. H., and Steighner, R. J. (1989) Structure of bleomycin-induced DNA double-strand breaks: predominance of blunt ends and single-base 5? extensions Biochemistry 28, 5808-5814
6. Roy, B. and Hecht, S. M. (2014) Hairpin DNA sequences bound strongly by bleomycin exhibit enhanced double-strand cleavage J. Am. Chem. Soc. 136, 4382-4393
7. Silberstein, E. B., Kornblut, A., Shumrick, D. A., and Saenger, E. L. (1974) 67Ga as a diagnostic agent for the detection of head and neck tumors and lymphoma Radiology 110, 605-608
8. Jones, S. E., Lilien, D. L., O'Mara, R. E., Durie, B. G. M., and Salmon, S. E. (1975) Indium-111 bleomycin tumor scanning in lymphoma Med. Pediatr. Oncol. 1, 11-21
9. Silverstein, M. J., Verma, R. C., Greenfield, L., and Morton, D. L. (1976) 111Indium-bleomycin breast and axilla imaging Cancer 37, 36-42
10. Rasker, J. J., Beekhuis, H., van de Wal, A. M., Homan van der Heide, J. N., and Woldring, M. G. (1976) Cobalt-57-bleomycin scanning of hila and mediastinum in patients with bronchial carcinoma: a prospective study Thorax 31, 641-649
11. Burton, I. E., Todd, J. H., and Turner, R. L. (1977) Static and dynamic imaging with indium-111 labelled bleomycin in the localization of squamous cell neoplasia Br. J. Radiol. 50, 508-512
12. Bekerman, C., Moran, E. M., Hoffer, P. B., Hendrix, R. W., and Gottschalk, A. (1977) Scintigraphic evaluation of lymphoma: a comparative study of 67Ga-citrate and 111In-bleomycin Radiology 123, 687-694
13. DeRiemer, L. H., Meares, C. F., Goodwin, D. A., and Diamanti, C. I. (1979) BLEDTA: tumor localization by a bleomycin analog containing a metal-chelating group J. Med. Chem. 22, 1019-1023
14. Goodwin, D. A., Meares, C. F., DeRiemer, L. H., Diamanti, C. I., Goode, R. L., Baumert, J. E., Sartoris, D. J., Lantieri, R. L., and Fawcett, H. D. (1981) Clinical studies with In-111 BLEDTA, a tumor-imaging conjugate of bleomycin with a bifunctional chelating agent J. Nucl. Med. 22, 787-792
15. Chapuis, J.-C., Schmaltz, R. M., Tsosie, K. S., Belohlavek, M., and Hecht, S. M. (2009) Carbohydrate dependent targeting of cancer cells by bleomycin-microbubble conjugates J. Am. Chem. Soc. 131, 2438-2439
16. Kansas, G. S. (1996) Selectins and their ligands: current concepts and controversies Blood 88, 3259-3287
17. Tiemeyer, M. and Goodman, C. S. (1996) Gilolectin is a novel carbohydrate-binding protein expressed by a subset of gila in the embryonic Drosphila nervous system Development 122, 925-936
18. Sacchettini, J. C., Baum, L. G., and Brewer, C. F. (2001) Multivalent protein-carbohydrate interactions. A new paradigm for supramolecular assembly and signal transduction Biochemistry 40, 3009-3015
19. Geijtenbeek, T. B. H., Torensma, R., van Vliet, S. J., van Duijnhoven, G. C. F., Adema, G. J., van Kooyk, Y., and Figdor, C. G. (2000) Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses Cell 100, 575-585
20. Lis, H. and Sharon, N. (1998) Lectins: carbohydrate-specific proteins that mediate cellular recognition Chem. Rev. 98, 637-674
21. Yu, Z., Schmaltz, R. M., Bozeman, T. C., Paul, R., Rishel, M. J., Tsosie, K. S., and Hecht, S. M. (2013) Selective tumor cell targeting by the disaccharide moiety of bleomycin J. Am. Chem. Soc. 135, 2883-2886
22. Bhattacharya, C., Yu, Z., Rishel, M. J., and Hecht, S. M. (2014) The carbamoylmannose moiety of bleomycin mediates selective tumor cell targeting Biochemistry 53, 3264-3266
23. Ogawa, T. and Sasajima, K. (1981) Synthetic studies on cell surface glycans. Part 4. Reconstruction of glycan chains of glycoprotein: branching mannopentaoside and mannohexaoside Tetrahedron 37, 2787-2792
24. Dondoni, A., Marra, A., and Massi, A. (1997) Carbohydrate homologation by the use of 2-(trimethylsilyl)thiazole. Preparative scale synthesis of rare sugars: l -gulose, l -idose, and the disaccharide subunit of bleomycin A2 J. Org. Chem. 62, 6261-6267
25. West, R. M., Bosworth, N., and Mujumdar, R. B. (2005) Cyanine dye labelling reagents. PCT Int. Appl. WO2005044923 A1 20050519.
26. Aspland, S. E., Ballatore, C., Castillo, R., Desharnais, J., Eustaquio, T., Goelet, P., Guo, Z., Li, Q., Nelson, D., Sun, C., Castellino, A. J., and Newman, M. J. (2006) Kinase-mediated trapping of bi-functional conjugates of paclitaxel or vinblastine with thymidine in cancer cells Bioorg. Med. Chem. Lett. 16, 5194-5198
27. Cox, D. J., Smith, M. D., and Fairbanks, A. J. (2010) Glycosylation catalyzed by a chiral Brønsted acid Org. Lett. 12, 1452-1455
28. Boger, D. L. and Honda, T. (1994) Total synthesis of bleomycin A2 and related agents. 4. Synthesis of the disaccharide subunit 2- O -(3- O -carbamoyl-?- d -mannopyranosyl)- l -gulopyranose and completion of the total synthesis of bleomycin A2 J. Am. Chem. Soc. 116, 5647-5656
29. Miyashita, H., Kai, Y., Nohara, T., and Ikeda, T. (2008) Efficient synthesis of ?- and ?-chacotriosyl glycosides using appropriate donors, and their cytotoxic activity Carbohydr. Res. 343, 1309-1315
30. Carter, P. J. and Senter, P. D. (2008) Antibody-drug conjugates for cancer therapy Cancer J. 14, 154-169
31. Ducry, L. and Stump, B. (2010) Antibody-drug conjugates: linking cytotoxic payloads to monoclonal antibodies Bioconjugate Chem. 21, 5-13
32. Krop, I. E., Beeram, M., Modi, S., Jones, S. F., Holden, S. N., Yu, W., Girish, S., Tibbitts, J., Yi, J.-H., Sliwkowski, M. X., Jacobson, F., Lutzker, S. G., and Burris, H. A. (2010) Phase I study of trastuzumab-DM1, an HER2 antibody-drug conjugate, given every 3 weeks to patients with HER2-positive metastatic breast cancer J. Clin. Oncol. 28, 2698-2704
33. Schroeder, B. R., Ghare, M. I., Bhattacharya, C., Paul, R., Yu, Z., Zaleski, P. A., Bozeman, T. C., Rishel, M. J., and Hecht, S. M. (2014) The disaccharide moiety of bleomycin facilitates uptake by cancer cells J. Am. Chem. Soc. 136, 13641-13656